IL-17 receptor — Drug Target

3 drugs 1 marketed

All drugs that target IL-17 receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

small molecule · Immunomodulator · IL-17 receptor antagonist

Marketed (1)

Induction- PF-06480605 450 mg SC Q4W · Pfizer · small molecule · Immunology
PF-06480605 is a small molecule that targets the IL-17 pathway to treat inflammatory conditions.

Phase 2 pipeline (2)

DPK-060 · DermaGen AB · Immunomodulator · Dermatology
DPK-060 is a topical treatment that modulates the immune response to reduce inflammation.
DC-806 · DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company · IL-17 receptor antagonist · Inflammatory diseases
DC-806 is an anti-inflammatory monoclonal antibody targeting the IL-17 receptor.